Radiation after immunotherapy for melanoma that spread to a sentinel node
Part of Cancer, Skin clinical trials.
This Phase 2 trial tests whether adding radiation to the lymph node area can help people with melanoma that has a positive sentinel lymph node. It is meant for patients without spread to distant organs, who are already planning to receive post-surgery immunotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have melanoma that was found in the sentinel lymph node after surgery, with higher-risk features
- You are planning to start immunotherapy after your surgery
- Your scans and exam show no spread to distant parts of the body
- No lymph nodes were known to be involved before the sentinel node biopsy
- You have not had lymph-node radiation before in the area that would overlap with this trial’s radiation plan
- You can take part in follow-up and you can consent; your health status is ECOG 3 or less and life expectancy is over 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a specific type of lymph node surgery, combined with a short course of immunotherapy (medicines that help your immune system fight cancer), works better for melanoma that has spread to nearby lymph nodes. It's for people whose melanoma can be removed and who are healthy enough for treatment.
This trial tests if giving radiation after surgery can help people with non-small cell lung cancer that has spread to multiple lymph nodes in the chest. It may offer a treatment option for those who have not had chemotherapy or immunotherapy before.
This trial tests whether adding radiation to immunotherapy (a drug that helps the immune system fight cancer) is better than using immunotherapy alone for people with non-small cell lung cancer that still has cancer in the lymph nodes after surgery and chemotherapy.
This trial tests if combining targeted radiation (SBRT) with standard immunotherapy works better for melanoma that has spread to a few spots in the body (but not the brain). It is for people who have not yet had treatment for their current spread.
This trial is testing whether giving radiation to nearby lymph nodes after surgery can help prevent breast cancer from coming back. It is for women with a specific type of breast cancer that has spread to a few lymph nodes but can be removed with surgery.
This trial looks at whether adding targeted radiation to lymph nodes after breast surgery can lower the chance of breast cancer coming back in people with higher-risk, node-negative disease. If you qualify, you may get a planned radiation approach designed for prevention, not treatment of spread.
Hear when a new Melanoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.